Fig. 13
From: Safety and efficacy of biological agents in the treatment of Systemic Lupus Erythematosus (SLE)
Infusion related adverse events
Fig. 13 | BMC Rheumatology
From: Safety and efficacy of biological agents in the treatment of Systemic Lupus Erythematosus (SLE)
Infusion related adverse events